Repeated naloxone administration in schizophrenia
- 1 August 1984
- journal article
- research article
- Published by Elsevier in Psychiatry Research
- Vol. 12 (4), 297-312
- https://doi.org/10.1016/0165-1781(84)90046-5
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Effects of acute and chronic haloperidol treatment on the concentrations of immunoreactive β-endorphin in plasma, pituitary and brain of ratsNeuropharmacology, 1982
- β-endorphin and β-lipotropin plasma levels in chronic schizophrenia, primary affective disorders and secondary affective disordersPsychoneuroendocrinology, 1981
- Artificial Organs: Thoughts & Progress:Plasma β‐Endorphin Levels In Chronic Schizophrenic Patients and Normal ControlsArtificial Organs, 1979
- Distribution of β‐endorphin in normal and schizophrenic human brainsEuropean Journal of Clinical Investigation, 1979
- C.S.F. β-ENDORPHIN IN SCHIZOPHRENIAThe Lancet, 1979
- THE MECHANISM OF PLACEBO ANALGESIAThe Lancet, 1978
- Endorphins in human cerebrospinal fluid: Clinical correlations to some psychotic statesActa Psychiatrica Scandinavica, 1978
- Naloxone-induced reversal of schizophrenic hallucinationsJournal of Neural Transmission, 1977
- Identification of two related pentapeptides from the brain with potent opiate agonist activityNature, 1975
- Morphine-like ligand for opiate receptors in human CSFLife Sciences, 1975